In 2023, Japan imported cortisone, hydrocortisone, prednisone, and prednisolone worth approximately 6.02 million USD. The forecasts predict a gradual decline from 2024 with import values decreasing year-on-year. Specifically, from 2024's 5.98 million USD to 5.84 million USD by 2028. This indicates a downward trend with a Compound Annual Growth Rate (CAGR) reflecting a consistent reduction in import value over the five-year period.

Future trends to watch for:

Potential impact of domestic production advancements in Japan.
Changes in healthcare policies affecting demand for these importations.
Global market shifts influencing raw materials or alternative medical solutions.